These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 23427117)
1. Detection of the selective androgen receptor modulator S-4 (Andarine) in a doping control sample. Starcevic B; Ahrens BD; Butch AW Drug Test Anal; 2013 May; 5(5):377-9. PubMed ID: 23427117 [No Abstract] [Full Text] [Related]
2. Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens. Thevis M; Gerace E; Thomas A; Beuck S; Geyer H; Schlörer N; Kearbey JD; Dalton JT; Schänzer W Drug Test Anal; 2010; 2(11-12):589-98. PubMed ID: 20967890 [TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes. Thevis M; Thomas A; Fusshöller G; Beuck S; Geyer H; Schänzer W Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2245-54. PubMed ID: 20623476 [TBL] [Abstract][Full Text] [Related]
4. Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control. Garg N; Hansson A; Knych HK; Stanley SD; Thevis M; Bondesson U; Hedeland M; Globisch D Org Biomol Chem; 2018 Jan; 16(5):698-702. PubMed ID: 29319101 [TBL] [Abstract][Full Text] [Related]
5. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls. Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598 [TBL] [Abstract][Full Text] [Related]
6. Detection of selective androgen receptor modulator YK-11 in a doping control sample. Sobolevsky T; Kucherova Y; Ahrens B Drug Test Anal; 2024 Jun; 16(6):655-660. PubMed ID: 37946705 [No Abstract] [Full Text] [Related]
7. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes. Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998 [TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Vivo Human Metabolism of Ostarine, a Selective Androgen Receptor Modulator and Doping Agent. Taoussi O; Bambagiotti G; Gameli PS; Daziani G; Tavoletta F; Tini A; Basile G; Lo Faro AF; Carlier J Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063049 [TBL] [Abstract][Full Text] [Related]
9. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. Thevis M; Geyer H; Kamber M; Schänzer W Drug Test Anal; 2009 Aug; 1(8):387-92. PubMed ID: 20355219 [TBL] [Abstract][Full Text] [Related]
10. Reference standards to underpin the detection of steroid abuse by athletes. Mackay LG Anal Bioanal Chem; 2008 Jun; 391(3):911-3. PubMed ID: 18278486 [No Abstract] [Full Text] [Related]
11. The use of a simple backflush technology to improve sample throughput and system robustness in routine gas chromatography tandem mass spectrometry analysis of doping control samples. Gray BP; Teale P J Chromatogr A; 2010 Jul; 1217(28):4749-52. PubMed ID: 20627253 [TBL] [Abstract][Full Text] [Related]
12. Aryl-propionamide-derived selective androgen receptor modulators: liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes. Kuuranne T; Leinonen A; Schänzer W; Kamber M; Kostiainen R; Thevis M Drug Metab Dispos; 2008 Mar; 36(3):571-81. PubMed ID: 18086831 [TBL] [Abstract][Full Text] [Related]
13. Detection of the selective androgen receptor modulator andarine (S-4) in a routine equine blood doping control sample. Cawley AT; Smart C; Greer C; Liu Lau M; Keledjian J Drug Test Anal; 2016 Feb; 8(2):257-61. PubMed ID: 26456227 [No Abstract] [Full Text] [Related]
14. Use of an electrochemically synthesised metabolite of a selective androgen receptor modulator for mass spectrometry-based sports drug testing. Thevis M; Lohmann W; Schrader Y; Kohler M; Bornatsch W; Karst U; Schänzer W Eur J Mass Spectrom (Chichester); 2008; 14(3):163-70. PubMed ID: 18708696 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing. Thevis M; Lagojda A; Kuehne D; Thomas A; Dib J; Hansson A; Hedeland M; Bondesson U; Wigger T; Karst U; Schänzer W Rapid Commun Mass Spectrom; 2015 Jun; 29(11):991-9. PubMed ID: 26044265 [TBL] [Abstract][Full Text] [Related]
16. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays. Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037 [TBL] [Abstract][Full Text] [Related]
17. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry. Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123 [TBL] [Abstract][Full Text] [Related]
18. Stable isotope ratio analysis in sports anti-doping. Cawley A Drug Test Anal; 2012 Dec; 4(12):891-2. PubMed ID: 23255318 [No Abstract] [Full Text] [Related]
19. SARM-S4 and metabolites detection in sports drug testing: a case report. Grata E; Perrenoud L; Saugy M; Baume N Forensic Sci Int; 2011 Dec; 213(1-3):104-8. PubMed ID: 21816554 [TBL] [Abstract][Full Text] [Related]
20. Metabolism and excretion of anabolic steroids in doping control--new steroids and new insights. Van Eenoo P; Delbeke FT J Steroid Biochem Mol Biol; 2006 Nov; 101(4-5):161-78. PubMed ID: 17000101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]